Drawing for XENTER

USPTO serial 90375393

XENTER

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
BECHHOFER, YOCHEVED D
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with XENTER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John C. Stringham

John C. Stringham WORKMAN NYDEGGER60 E. SOUTH TEMPLE, SUITE 1000SALT LAKE CITY, UT 84111United States

Goods and services

ClassDescriptionStatusFirst use
042Computer services, namely, providing an online medical database for collecting and sharing performance data related to medical procedures and postoperative patient outcomes for medical research purposes; creating an online platform for healthcare professionals for the purpose of sharing information regarding medical procedures and treatment; providing temporary use of online non-downloadable computer software and mobile applications for creating, offering, hosting and delivering online demonstrations and presentations in the field of medical devices and surgical procedures; providing temporary use of online non-downloadable computer software and mobile applications to assist healthcare professionals with programming medical devices; providing temporary use of online non-downloadable computer software and mobile applications for use in invasive vascular and structural interventions, cardiac care, imaging of cardiovascular and neurological systems, physiological assessments and medical assessments, namely, atherosclerotic lesion morphology and analytical predictive intraoperative histopathology; providing temporary use of online non-downloadable computer software and mobile applications for use in gathering, utilizing, storing, obtaining, viewing, manipulating, querying, analyzing, reporting and sharing medical images, physiological assessments, medical information and data; providing temporary use of online non-downloadable computer software and mobile applications for viewing, manipulating, querying, gathering, utilizing, storing and sharing images and data, obtaining medical information, and storing patient data for use in applied data and integrated solutions, namely, guidewires, catheters and needles; providing temporary use of online non-downloadable computer software and mobile applications for viewing, manipulating, querying, gathering, utilizing, storing and sharing images and data, obtaining medical information, and storing patient data for use with physical intelligence medical devices; providing temporary use of online non-downloadable computer software and mobile applications for viewing, manipulating, querying, gathering, utilizing, storing and sharing images and data, obtaining medical information, and storing patient data for use in interventional, cardiovascular, and neurovascular procedures; providing temporary use of online non-downloadable computer software and mobile applications for gathering, utilizing, storing, obtaining, viewing, manipulating, querying, analyzing, reporting and sharing medical images, physiological assessments, medical information and data for use in interventional, cardiovascular and neurovascular procedures; providing temporary use of online non-downloadable computer software and mobile applications for viewing, manipulating, querying, gathering, utilizing, storing and sharing images and data, obtaining medical information, and storing patient data for use in esophagus, head and other organ procedures; providing temporary use of online non-downloadable computer software and mobile applications for viewing, manipulating, querying, gathering, utilizing, storing and sharing images and data, obtaining medical information, and storing patient data for use in procedures involving solid tumors; providing temporary use of online non-downloadable computer software and mobile applications for viewing, manipulating, querying, gathering, utilizing, storing and sharing images and data, obtaining medical information, and storing patient data for use with imaging software in interventional and cardiovascular procedures and related devices, namely, guidewires, catheters, and needles; providing temporary use of online non-downloadable computer software and mobile applications for use with gathering, analyzing and reporting hemodynamic and physiologic information; providing temporary use of online non-downloadable computer software and mobile applications for identifying tip location of catheters and guidewires; providing temporary use of online non-downloadable computer software and mobile applications for viewing, manipulating, querying, gathering, utilizing, storing and sharing images and data, obtaining medical information, and storing patient data for physically intelligent devices, namely, intelligent guidewires, intelligent catheters, and intelligent needles; providing temporary use of online non-downloadable computer software and mobile applications for viewing, manipulating, querying, gathering, utilizing, storing and sharing images and data, obtaining medical information, and storing patient data for use in orthopaedic, spine, and joint surgical procedures; providing temporary use of online non-downloadable computer software and mobile applications for viewing, manipulating, querying, gathering, utilizing, storing and sharing images and data, obtaining medical information, and storing patient data for use in orthopaedic, spine, and joint minimally invasive surgical procedures; providing temporary use of online non-downloadable computer software and mobile applications for use in blood profiling including blood analysis, and blood flow, and blood location procedures using catheters and needles; medical research in the field of medical and surgical apparatus, appliances, instruments and therapies; medical research in the development of surgical and minimally invasive techniques and procedures; design and development of medical, surgical, and minimally invasive products, apparatus, equipment, instruments and preparations, and advisory services theretoACTIVE
044Computer services, namely, providing an online medical database for collecting and sharing performance data related to medical procedures and postoperative patient outcomes for medical diagnostic and treatment purposesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 8, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 8, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 23, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 23, 2026EX5GSOU EXTENSION 5 GRANTED
Apr 23, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 29, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 28, 2025EXT5SOU EXTENSION 5 FILED
Apr 25, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 25, 2025EX4GSOU EXTENSION 4 GRANTED
Apr 24, 2025EXT4SOU EXTENSION 4 FILED
Apr 24, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 30, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 30, 2024EX3GSOU EXTENSION 3 GRANTED
Oct 30, 2024EXT3SOU EXTENSION 3 FILED
Oct 30, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 27, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 26, 2024EX2GSOU EXTENSION 2 GRANTED
Apr 26, 2024EXT2SOU EXTENSION 2 FILED
Apr 26, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 28, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 26, 2023EX1GSOU EXTENSION 1 GRANTED
Oct 26, 2023EXT1SOU EXTENSION 1 FILED
Oct 26, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 2, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 7, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 7, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 15, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 27, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jan 27, 2023XAECEXAMINER'S AMENDMENT ENTERED
Jan 27, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 27, 2023GNEAEXAMINERS AMENDMENT E-MAILED
Jan 27, 2023CNEAEXAMINERS AMENDMENT -WRITTEN
Jan 6, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jan 5, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 5, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 22, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 22, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 22, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 22, 2022ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN
May 17, 2022PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY
May 4, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Apr 15, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Apr 14, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 14, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 21, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 21, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 21, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 16, 2021ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN
Nov 2, 2021PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY
Oct 14, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Oct 1, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Sep 30, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 2, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 2, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 2, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 30, 2021DOCKASSIGNED TO EXAMINER
Mar 11, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 11, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 11, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 18, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 15, 2020NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance